[Hyperuricemia and the metabolic syndrome]
F Mitu1, Mihaela Veronica Drăgan
1Clinica a VI-a Medicală, Facultatea de Medicină, Universitatea de Medicină si Farmacie "Gr.T. Popa" Iaşi.
Summary
High uric acid levels (hyperuricemia) are linked to metabolic issues and cardiovascular risk. In low-risk individuals, it may be benign, but in high-risk patients, it could indicate serious heart and vessel stress.
Area of Science:
- Biochemistry
- Human Physiology
- Metabolic Disorders
Background:
- Uric acid, the end product of purine metabolism, has complex pathophysiologic aspects.
- Historically linked to gout, hyperuricemia is now recognized as a marker for metabolic and hemodynamic abnormalities.
- High prevalence of metabolic syndrome observed in hyperuricemic patients.
Purpose of the Study:
- To explore the role of hyperuricemia in cardiovascular risk.
- To differentiate the implications of asymptomatic hyperuricemia based on cardiovascular risk stratification.
- To investigate potential pathogenetic factors in high-risk hyperuricemic individuals.
Main Methods:
- Review of recent epidemiologic studies on hyperuricemia and cardiovascular risk.
- Analysis of factors contributing to diminished renal uric acid clearance.
- Hypothesis formulation regarding hyperuricemia's role in inflammatory, ischemic, and oxidative stresses.
Main Results:
- Asymptomatic hyperuricemia in low cardiovascular risk patients may stem from reduced renal clearance and have a benign outcome.
- Hyperuricemia in high cardiovascular risk patients might indicate additional pathogenetic factors.
- Potential links between hyperuricemia and inflammatory, ischemic, or oxidative stresses in the cardiovascular system.
Conclusions:
- Hyperuricemia's clinical significance varies with cardiovascular risk.
- Further research, including randomized controlled trials, is needed to test the hypothesis in high-risk populations.
- Understanding hyperuricemia's role in cardiovascular disease requires further investigation into its pathogenetic mechanisms.
Related Concept Videos
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:19Overview of Carbohydrate Metabolism
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...